India's Sun Pharmaceutical Industries Limited and Bayer have signed an agreement allowing Sun Pharma to market and distribute a second brand of the drug finerenone in India under the brand name Lyvelsa. Finerenone is a patented medicine indicated to reduce the risk of sustained decline in kidney function, end-stage kidney...
U.S. Announces Tariff Hikes on Chinese Products
The Biden administration has announced significant tariff increases on Chinese products in several key sectors, including semiconductors, electric vehicles, batteries, and medical products. These hikes are aimed at pressuring China to eliminate unfair trade practices related to technology transfer, intellectual property rights, and innovation, according to a White House statement....

